Ruscetti S, Davis L, Feild J, Oliff A
J Exp Med. 1981 Sep 1;154(3):907-20. doi: 10.1084/jem.154.3.907.
In these studies, we have shown data that are consistent with the hypothesis that mink cell focus-inducing viruses (MCF) play an important role in the generation of an erythroproliferative disease developing after injection of certain strains of newborn mice with ecotropic Friend murine leukemia virus (F-MuLV). Resistance to this disease is correlated with the endogenous expression of an MCF/xenotropic virus-gp70-related protein that may interfere with the replication or spread of MCF viruses. These ideas are supported by the following observations: (a) after infection with F-MuLV, only 6/13 strains of mice-developed disease, and studies with crosses between susceptible and resistant strains indicated that resistance was dominant. Although F-MuLV was shown to replicate equally well in all strains tested, viruses coding for MCF-specific viral envelope proteins could be detected only in the spleens of mice from strains that were resistant to F-MuLV-induced disease and not in the spleens of mice from strains that were resistant to F-MuLV-induced disease; (b) a Friend MCF (Fr-MCF) virus isolated from the spleen of an F-MuLV-infected mouse from a susceptible strain induced the same erythroproliferative disease when injected as an appropriate pseudotype into mice from susceptible but not resistant strains of mice; and (c) resistant but not susceptible strains of mice endogenously express MCF/xenotropic virus-related envelope glycoproteins that may be responsible for resistance by blocking receptors for MCF viruses. These results not only indicate that Fr-MCF virus is a crucial intermediate in the induction of disease by F-MuLV, but also suggest that a novel gene, either an MCF/xenotropic virus-related envelope gene or a gene controlling its expression, is responsible for resistance to erythroleukemia induced by F-MuLV.
在这些研究中,我们已展示的数据与以下假说相符:水貂细胞融合诱导病毒(MCF)在某些品系新生小鼠注射嗜亲性Friend鼠白血病病毒(F-MuLV)后发生的红细胞增殖性疾病的发生过程中起重要作用。对该疾病的抗性与一种MCF/异嗜性病毒-gp70相关蛋白的内源性表达相关,该蛋白可能会干扰MCF病毒的复制或传播。以下观察结果支持了这些观点:(a)感染F-MuLV后,只有6/13品系的小鼠发病,对易感品系和抗性品系进行杂交研究表明抗性是显性的。尽管F-MuLV在所有测试品系中复制情况相同,但仅在对F-MuLV诱导疾病具有抗性的品系小鼠脾脏中能检测到编码MCF特异性病毒包膜蛋白的病毒,而在对F-MuLV诱导疾病敏感的品系小鼠脾脏中未检测到;(b)从易感品系的F-MuLV感染小鼠脾脏中分离出的Friend MCF(Fr-MCF)病毒,以适当假型注射到易感但非抗性品系的小鼠中时,会诱发相同的红细胞增殖性疾病;(c)抗性而非易感品系的小鼠内源性表达MCF/异嗜性病毒相关包膜糖蛋白,这些糖蛋白可能通过阻断MCF病毒的受体而导致抗性。这些结果不仅表明Fr-MCF病毒是F-MuLV诱导疾病的关键中间体,还表明一个新基因,要么是MCF/异嗜性病毒相关包膜基因,要么是控制其表达的基因,对F-MuLV诱导的红白血病抗性负责。